RTSN RETENSION PHARMACEUTICALS IN
FollowCommon Stock, par value $0.0001 per share (common), issuer CIK 2002988
No 13F filer reports this security in the loaded quarters.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- LYTTON LAURENCE W (group LYTTON LAURENCE W)
617,207 shares, 7.4% in a 13G as of 2026-10-13,0000935836-26-000533
Accepted , ingested - B Group, Inc.(group B Group, Inc.)
833,333 shares, 10% in a 13G as of 2026-10-13,0001213900-26-110378
Accepted , ingested - Keller Eric L.
598,598 shares, 7.07% in a 13D as of 2026-10-13,0001213900-26-109425
Accepted , ingested - PVG ASSET MANAGEMENT CORP
1,002,050 shares, 8.3% in a 13G as of 2026-10-09,0000820434-26-000008
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
Events
B Group, Inc. and 2 other reporting persons reported 833,333 RTSN shares, 10% of the class, as of 2026-10-13, in a 13G filed 2026-10-16. 0001213900-26-110378
Accepted , ingestedPVG ASSET MANAGEMENT CORP reported 1,002,050 RTSN shares, 8.3% of the class, as of 2026-10-09, in a 13G filed 2026-10-16. 0000820434-26-000008
Accepted , ingestedLYTTON LAURENCE W reported 617,207 RTSN shares, 7.4% of the class, as of 2026-10-13, in a 13G filed 2026-10-15. 0000935836-26-000533
Accepted , ingestedKeller Eric L. reported 598,598 RTSN shares, 7.07% of the class, as of 2026-10-13, in a 13D filed 2026-10-14. 0001213900-26-109425
Accepted , ingested